Diagnosis of ovarian carcinoma histotype based on limited sampling: A prospective study comparing cytology, frozen section, and core biopsies to full pathologic examination

International Journal of Gynecological Pathology

Volumn 34, Issue 6, 2015, Pages 517-527

  Hoang, Lien N ^a   Zachara, Susanna ^a   Soma, Anita ^b   Köbel, Martin ^c   Lee, Cheng Han ^d   McAlpine, Jessica N ^e   Huntsman, David ^a,e,f   Thomson, Thomas ^f   Van Niekerk, Dirk ^f   Singh, Naveena ^g   Gilks, C Blake ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b KING EDWARD MEMORIAL HOSPITAL   (Australia)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f BRITISH COLUMBIA CANCER AGENCY   (Canada)

^g BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

Core needle biopsy; Cytology; Fine needle aspiration; Frozen section; Histotype prediction; Immunohistochemistry; Intraoperative consultation; Ovarian carcinoma

Indexed keywords

ARID1A PROTEIN; HEPATOCYTE NUCLEAR FACTOR 1BETA; PROGESTERONE RECEPTOR; PROTEIN; PROTEIN P16; PROTEIN P53; TREFOIL FACTOR 3; UNCLASSIFIED DRUG; VIMENTIN; WT1 PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BRENNER TUMOR; CANCER ADJUVANT THERAPY; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; COLLOID CARCINOMA; CORE NEEDLE BIOPSY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; DYSGERMINOMA; ENDOMETRIOID CARCINOMA; FEMALE; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MITOSIS RATE; NEEDLE BIOPSY; NEUROENDOCRINE CARCINOMA; NEUROENDOCRINE TUMOR; OVARY CARCINOMA; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROMUCINOUS CARCINOMA; SEROUS BORDERLINE TUMOR; TERATOMA; TUMOR VOLUME; CARCINOMA; COMPARATIVE STUDY; CYTODIAGNOSIS; LARGE CORE NEEDLE BIOPSY; MIDDLE AGED; OVARIAN NEOPLASMS; PATHOLOGY; PROCEDURES; STANDARDS; YOUNG ADULT;

ADULT; AGED; BIOMARKERS, TUMOR; BIOPSY, LARGE-CORE NEEDLE; CARCINOMA; CYTODIAGNOSIS; FEMALE; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARIAN NEOPLASMS; PATHOLOGY, SURGICAL; YOUNG ADULT;

EID: 84943625818     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0000000000000199     Document Type: Article

References (44)

1. Kurman RJ, Carcangiu ML, Herrington CS, et al, eds. World Health Organization Classification of Tumours of Female Reproductive Organs (4th Edition). Lyon: IARC Press; 2014.
2. Gurung A, Hung T, Morin J, et al. Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates. Histopathology 2013;62:59-70.
3. Kurman RJ, Shih IM. Molecular pathogenesis and extra-ovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum Pathol 2011;42:918-31.
4. Despierre E, Yesilyurt BT, Lambrechts S, et al. Epithelial ovarian cancer: rationale for changing the one-fits-all standard treatment regimen to subtype-specific treatment. Int J Gynecol Cancer 2014;24:468-77.
5. Lalwani N, Prasad SR, Vikram R, et al. Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiogr 2011;31:625-46.
6. Lim D, Oliva E. Precursors and pathogenesis of ovarian carcinoma. Pathology 2013;45:229-42.
7. Bookman MA, Gilks CB, Kohn EC, et al. Better therapeutic trials in ovarian cancer. J Natl Cancer Inst 2014;106: dju029.
8. Galic V, Coleman RL, Herzog TJ. Unmet needs in ovarian cancer: dividing histologic subtypes to exploit novel targets and pathways. Curr Cancer Drug Targets 2013;13:698-707.
9. Dancey J. Targeted therapies and clinical trials in ovarian cancer. Ann Oncol 2013;24:59-63.
10. Fujiwara K, Yoshida H, Hasegawa K. Update on nonserous ovarian cancer trials. Ann Oncol 2013;24:46-7.
11. Hess V, A'Hern R, Nasiri N, et al. Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment. J Clin Oncol 2004;22:1040-4.
12. Sugiyama T, Kamura T, Kigawa J, et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 2000;88:2584-9.
13. Vang R, Shih IM, Kurman RJ. Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol 2009;16:267-82.
14. Prat J. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch 2012;460:237-49.
15. Morgan RJ, Alvarez RD, Armstrong DK, et al. NCCN Clinical Practice Guidelines in Oncology: epithelial ovarian cancer. J Nat Compr Canc Netw 2011;9:82-113.
16. Abbruzzese JL, eds. Clinical Trials [database online]. Bethes-da, MD: National Cancer Institute. Updated; 2014.
17. Onda T, Yoshikawa H. Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions. Expert Rev Anticancer Ther 2011;11:1053-67.
18. Kobel M, Kalloger SE, Lee S, et al. Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium. Cancer Epidemiol Biomark Prev 2013;22:1677-86.
19. Malipatil R, Crasta JA. How accurate is intraoperative frozen section in the diagnosis of ovarian tumors?. J Obstet Gynaecol Res 2013;39:710-13.
20. Pinto PB, Andrade LA, Derchain SF. Accuracy of intra-operative frozen section diagnosis of ovarian tumors. Gynecol Oncol 2001;81:230-2.
21. Tangjitgamol S, Jesadapatrakul S, Manusirivithaya S, et al. Accuracy of frozen section in diagnosis of ovarian mass. Int J Gynecol Cancer 2004;14:212-9.
22. Lim FK, Yeoh CL, Chong SM, et al. Pre and intraoperative diagnosis of ovarian tumours: how accurate are we?. Aust N Z J Obstet Gynaecol 1997;37:223-7.
23. Stewart CJR, Brennan BA, Hammond IG, et al. Intraoperative assessment of clear cell carcinoma of the ovary. Int J Gynecol Pathol 2008;27:475-82.
24. Baker P, Oliva E. A practical approach to intraoperative consultation in gynecological pathology. Int J Gynecol Pathol 2008; 27: 353-65.
25. Takemoto S, Ushijima K, Kawano R, et al. Validity of intraoperative diagnosis at laparoscopic surgery for ovarian tumors. J Minim Invasive Gynecol 2004;21:576-9.
26. Toneva F, Wright H, Razvi K. Accuracy of frozen section in the diagnosis of ovarian tumours. J Obstet Gynaecol 2012;32:479-82.
27. Storms AA, Sukumvanich P, Monaco SE, et al. Mucinous tumors of the ovary: diagnostic challenges at frozen section and clinical implications. Gynecol Oncol 2012;125: 75-9.
28. Kokka F, Singh N, Reynolds K, et al. The accuracy of frozen section diagnosis in apparent early ovarian cancer-results from a UK centre. Histopathology 2009;55:756-8.
29. Kato N, Higuchi J, Ogata S, et al. Spherule-like acellular stroma in clear cell carcinoma of the ovary: its utility in frozen section diagnosis. Histopathology 2011;59:790-4.
30. Mettler TN, Manivel JC, Pambuccian SE. 'Raspberry bodies, ' extracellular hyaline globules and branching hyaline stromal fragments in a fine-needle aspirate of metastatic clear cell carcinoma of the ovary. Diagn Cytopathol 2014;42: 230-5.
31. Gramlich T, Austin RM, Lutz M. Histologic sampling requirements in ovarian carcinoma: a review of 51 tumors. Gynecol Oncol 1990;38:249-56.
32. Puls L, Heidtman E, Hunter JE, et al. The accuracy of frozen section by tumor weight for ovarian epithelial neoplasms. Gynecol Oncol 1997;67:16-9.
33. Zardawi IM. Fine needle aspiration cytology vs. core biopsy in a rural setting. Acta Cytol 1998;42:883-7.
34. Oge T, Yalcin OT, Ozalp SS, et al. Sonographically guided core biopsy: a minimally invasive procedure for managing adnexal masses. J Ultrasound Med 2013;32:2023-7.
35. Pombo F, Rodriguez E, Martin R, et al. CT-guided core-needle biopsy in omental pathology. Acta Radiol 1997;38:978-81.
36. Freedman OC, Dodge J, Shaw P, et al. Diagnosis of epithelial ovarian carcinoma prior to neoadjuvant chemotherapy. Gynecol Oncol 2010;119:22-5.
37. Altman AD, Nelson GS, Ghatage P, et al. The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors. Mod Pathol 2013;26:1255-63.
38. Egan JA, Ionescu MC, Eapen E, et al. Differential expression of WT1 and p53 in serous and endometrioid carcinomas of the endometrium. Int J Gynecol Pathol 2004;23:119-22.
39. Dupont J, Wang X, Marshall DS, et al. Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray. Gynecol Oncol 2004;94:449-55.
40. Coosemans A, Moerman P, Verbist G, et al. Wilms' tumor gene 1 (WT1) in endometrial carcinoma. Gynecol Oncol 2008;111: 502-8.
41. Gupta N, Rajwanshi A, Dhaliwal LK, et al. Fine needle aspiration cytology in ovarian lesions: an institutional experience of 584 cases. Cytopathol 2012;23:300-7.
42. Granados R. Aspiration cytology of ovarian tumors. Curr Opin Obstet Gynecol 1995;7:43-8.
43. Ganjei P, Dickinson B, Harrison T, et al. Aspiration cytology of neoplastic and non-neoplastic ovarian cysts: is it accurate?. Int J Gynecol Pathol 1996;15:94-101.
44. Lu D, Davila RM, Pinto KR, et al. ThinPrep evaluation of fluid samples aspirated from cystic ovarian masses. Diagn Cytopathol 2004;30:320-4.